Trombositopeni gebeliklerin %7-10'unda saptanan, trombosit sayısının düşüklüğüyle karakterize bir durumdur. Gebelikte görülen trombositopenin en sık sebebi gestasyonel trombositopenidir. Bu hastalarda trombositopeni genelde hafif olduğundan semptom görülmez. Tanı çoğunlukla bağ dokusu hastalıklarının,ilaç etkilerinin, obstetriyle ilişkili sebeplerin dışlanmasıyla konulur. Erken gebelik haftalarında görülen trombositopenin etyolojisinde en fazla otoimmun sebepler rol alır. Preeklampsi,HELLP sendromu gibi obstetriyle ilişkili nedenlere ikincil gelişen trombositopeniler ise her zaman akılda tutulmalıdır. Bu durumların varlığında çoğu zaman doğum gerçekleşmeden trombositopeni düzelmeyecektir. Klinisyen; tedavi gerektirmeyen trombositopenilerle,...
BACKGROUND: Literature is scarce on thrombocytopenia during pregnancy; hence, this study was done ...
Deep vein thrombosis during pregnancy is an important risk factor increasing maternal morbidity and ...
CILJ: Cilj ovog rada bio je istražiti i utvrditi moguću korist profilakse niskomolekulskim heparinom...
Trombocitopenija pogađa 6 do 10% trudnoća i druga je po učestalosti hematoloških bolesti u trudnoći....
Amaç: Gebelikte en sık görülen hematolojik komplikasyon olan trombositopeninin incelenmesi. Materyal...
Thrombocytopenia is a common finding in pregnancy, occuring in approximately 7-10% of pregnancies. ...
Objective: The assessment of thrombocytopenia in pregnancy which is the most frequently seen hematol...
Thrombocytopenia, defined as platelet count < 150,000 mm3, is frequently diagnosed by obstetricians ...
Thrombocytopenia affects 7 to 15% of all pregnant women and is the second common haematological prob...
In a normally progressing pregnancy, especially in thethird trimester thrombocyte numbers reduce by ...
Treball Final de Grau en Medicina. Codi: MD1158. Curs acadèmic: 2017/2018Thrombocytopenia during p...
Idiopatska trombocitopenična purpura je autoimuna bolest obilježena brojem trombocita manjim od 150 ...
Background: Thrombocytopenia is second to anemia as the most common hematological abnormality during...
Summary: Thrombocytopenia in pregnancy has many common causes, including gestational thrombocytopeni...
Trudnoća je obilježena brojnim fiziološkim promjenama u tijelu uključujući i promjenama u krvnom sus...
BACKGROUND: Literature is scarce on thrombocytopenia during pregnancy; hence, this study was done ...
Deep vein thrombosis during pregnancy is an important risk factor increasing maternal morbidity and ...
CILJ: Cilj ovog rada bio je istražiti i utvrditi moguću korist profilakse niskomolekulskim heparinom...
Trombocitopenija pogađa 6 do 10% trudnoća i druga je po učestalosti hematoloških bolesti u trudnoći....
Amaç: Gebelikte en sık görülen hematolojik komplikasyon olan trombositopeninin incelenmesi. Materyal...
Thrombocytopenia is a common finding in pregnancy, occuring in approximately 7-10% of pregnancies. ...
Objective: The assessment of thrombocytopenia in pregnancy which is the most frequently seen hematol...
Thrombocytopenia, defined as platelet count < 150,000 mm3, is frequently diagnosed by obstetricians ...
Thrombocytopenia affects 7 to 15% of all pregnant women and is the second common haematological prob...
In a normally progressing pregnancy, especially in thethird trimester thrombocyte numbers reduce by ...
Treball Final de Grau en Medicina. Codi: MD1158. Curs acadèmic: 2017/2018Thrombocytopenia during p...
Idiopatska trombocitopenična purpura je autoimuna bolest obilježena brojem trombocita manjim od 150 ...
Background: Thrombocytopenia is second to anemia as the most common hematological abnormality during...
Summary: Thrombocytopenia in pregnancy has many common causes, including gestational thrombocytopeni...
Trudnoća je obilježena brojnim fiziološkim promjenama u tijelu uključujući i promjenama u krvnom sus...
BACKGROUND: Literature is scarce on thrombocytopenia during pregnancy; hence, this study was done ...
Deep vein thrombosis during pregnancy is an important risk factor increasing maternal morbidity and ...
CILJ: Cilj ovog rada bio je istražiti i utvrditi moguću korist profilakse niskomolekulskim heparinom...